Product Information
QUETIAPINE FUMARATE 300 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.1442 per EA under NDC 68001018306. Its NADAC has been published 630 times since Jun 4, 2014.
Strength
300 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001018306
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA201109On Market Since
2/28/2013
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE FUMARATE 300 MG TAB has been published 630 times since Jun 4, 2014, and over the history we have for it it has declined 66.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1442 per EA |
|---|---|
| All-time high | $0.4513 (Nov 12, 2014) |
| All-time low | $0.1136 (Nov 20, 2024) |
| 52-week high | $0.1490 |
| 52-week low | $0.1265 |
| Median price | $0.1760 |
| Average price | $0.2162 |
| Largest weekly change | -26.7% (Nov 20, 2024) |
| Weeks tracked | 630 |
| Tracking since | Jun 4, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QUETIAPINE FUMARATE 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE FUMARATE 300 MG TAB, manufactured by BluePoint Laboratories, is $0.1442 per EA (NDC 68001018306), effective Jun 24, 2026.
How has the price of QUETIAPINE FUMARATE 300 MG TAB changed over time?
Over the history we have for it, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has declined 66.0%. It has been tracked across 630 weekly CMS publications since Jun 4, 2014.
What are the highest and lowest recorded NADAC prices for QUETIAPINE FUMARATE 300 MG TAB?
Since Jun 4, 2014, the NADAC for QUETIAPINE FUMARATE 300 MG TAB has ranged from a low of $0.1136 (Nov 20, 2024) to a high of $0.4513 (Nov 12, 2014), with a median of $0.1760 per EA.
Are there cheaper alternatives to QUETIAPINE FUMARATE 300 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as QUETIAPINE FUMARATE 300 MG TAB, but none are currently priced below it.
Who manufactures QUETIAPINE FUMARATE 300 MG TAB?
QUETIAPINE FUMARATE 300 MG TAB (NDC 68001018306) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification